Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mie Chen
Institution:
Nanjing Maternity and Child Health Care Hospital
Observed institutions:
Nanjing Maternity and Child Health Care Hospital,
Jiangsu Province Hospital,
Nanjing Medical University
ORCID:
0009-0008-9620-6746
Observed ORCID:
0009-0008-9620-6746
OpenAlex ID:
A5033699442
Dual pH/ROS‐Responsive Nanoplatform with Deep Tumor Penetration and Self‐Amplified Drug Release for Enhancing Tumor Chemotherapeutic Efficacy
2020
·
Yongfei Li
, Mie Chen
, et al.
·
Small
·
75
Transferrin receptor-targeted redox/pH-sensitive podophyllotoxin prodrug micelles for multidrug-resistant breast cancer therapy
2019
·
Yongfei Li
, Mie Chen
, et al.
·
Journal of Materials Chemistry B
·
63
Diselenium-linked dimeric prodrug nanomedicine breaking the intracellular redox balance for triple-negative breast cancer targeted therapy
2023
·
Mie Chen
, Min Zhang
, et al.
·
European Journal of Pharmaceutics and Biopharmaceutics
·
18
Serum and Fecal Metabolite Profiles Linking With Gut Microbiome in Triple-Negative Breast Cancer Patients
2024
·
Jiawei Liu
, Jing Shi
, et al.
·
Breast Cancer Basic and Clinical Research
·
11
Radiomic imaging models for predicting breast cancer prognosis based on Interleukin-18 (IL18)
2025
·
Qian Zhou
, Mie Chen
, et al.
·
BMC Medical Imaging
PDF
METTL3-Mediated m6A Modification of PSAT1 mRNA Promotes HER2-Positive Breast Cancer Resistance to Trastuzumab
2023
·
Yincheng Liu
, Jiahui Chu
, et al.
·
SSRN Electronic Journal
Show more works
View as search
Works count:
6
Citation count:
167
H-index:
4
I10-index:
4
Year
Topic
Type